People with schizophrenia have higher levels of antibodies to some Epstein-Barr virus (EBV) proteins (indicating an aberrant response to EBV infection) compared to those without schizophrenia, according to a study in Schizophrenia Bulletin.
Read more via Oxford Academic – Schizophrenia Bulletin.